Search clinical trials for: MAP0010 high dose

Total 10888 results

LanZhou University

Completed

The Organ Protection of Astragalus in Subjects With Metabolic Syndrome

Metabolic Syndrome

China
Boehringer Ingelheim

Completed

Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed Conditions

Healthy

Germany
Zhejiang University

Completed

The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia

Hyperlipoproteinemia
Molecular Partners AG

Completed

Study to Investigate the Safety, Blood Levels and Activity of MP0310 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

France
Centre Hospitalier Universitaire Vaudois

Recruiting

FLASH Radiotherapy for Skin Cancer (LANCE)

Basal Cell Carcinoma | Cutaneous Squamous Cell Carcinoma

Switzerland
Brown University

Completed

Behavioral Economic Analysis of Demand for Marijuana

Marijuana Smoking

United States
Samsung Medical Center
KSPNO stem cell transpantation committee

Unknown

High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors

Brain Tumor

Korea, Republic of
Stanford University

Completed

High Dose Chemotherapy Followed By PBSC Rescue for HD

Hodgkin Disease

United States
Stanford University

Completed

Autologous Stem Cell Rescue for Primary Amyloidosis

Amyloidosis | Blood and Marrow Transplant (BMT)

United States
Stanford University

Completed

High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

Multiple Myeloma

United States
Boehringer Ingelheim
Eli Lilly and Company

Completed

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

Diabetes Mellitus, Type 2

United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US

Influenza

United States
Pharvaris Netherlands B.V.

Recruiting

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema (RAPIDe-2)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditions

United States, Bulgaria, Czechia, Hungary, Spain, France, Germany, Poland, Canada, Israel
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 691751 in Healthy Asian Male Volunteers

Healthy

Korea, Republic of
Celon Pharma SA
National Center for Research and Development, Poland

Recruiting

Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients With Levodopa Induced Dyskinesia

Parkinson Disease | Dyskinesia, Medication-Induced

Poland, Ukraine
Ahon Pharmaceutical Co., Ltd.

Completed

Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects

Advanced Breast Cancer

China
Swedish Orphan Biovitrum

Completed

A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy (DISSOLVE I)

Chronic Gout

United States
AnaptysBio, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP (GEMINI1)

Generalized Pustular Psoriasis

United States, Australia, Georgia, Germany, Korea, Republic of, Malaysia, Morocco, Poland, Romania, Spain, Taiwan, Thailand, Tunisia, Turkey, Slovakia
GlaxoSmithKline

Terminated

Efficacy and Safety of Ambrisentan in Children 8-18yrs

Hypertension, Pulmonary

France, United States, Germany, Spain, Italy, Japan, Hungary, Russian Federation, Argentina
Pfizer

Completed

6-week Safety and PD Study in Adults With NAFLD

Non-alcoholic Fatty Liver Disease

United States
GeneScience Pharmaceuticals Co., Ltd.
The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaborators

Completed

A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA

Small for Gestational Age Infant

China
Inviragen Inc.

Completed

Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71

Hand, Foot and Mouth Disease

Singapore
Sichuan Haisco Pharmaceutical Group Co., Ltd

Completed

Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian Volunteers

Healthy

Australia
Mayo Clinic
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Gene Signatures of Influenza Vaccine Responses in Older Adults

Influenza

United States
AIDP, Inc.
KGK Science Inc.

Completed

Evaluating Efficacy of Investigational Products on Spontaneous Bowel Movements in Healthy People With ≤ 3 Complete Weekly Spontaneous Bowel Movements

Healthy | Functional Constipation

Canada
Anterogen Co., Ltd.

Terminated

Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211) (ANTG)

Perianal Fistula | Primary; Complex

Korea, Republic of
Anterogen Co., Ltd.

Terminated

Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex Fistula (ANTG-ASC-210)

Complex Perianal Fistula

Korea, Republic of
Purdue University
Grain processing corporation

Completed

The Attenuating Effect of Soluble Fiber Consumption on Postprandial Glycemia in Humans

Type2 Diabetes | Postprandial Hyperglycemia | Blood Sugar; High

United States
Cortria Corporation

Completed

A Study to Evaluate the Lipid Regulating Effects of TRIA-662

Hyperlipidemia
University of Colorado, Colorado Springs

Completed

Does Flaxseed Supplementation Improve Glycemic Control in Individuals With Pre-diabetes?

PreDiabetes

United States
Fu-Sheng Wang

Unknown

Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients

Human Immunodeficiency Virus | Disorder of Immune Reconstitution

China
Azura Ophthalmics
Syneos Health; Cliantha Research

Completed

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)

Dry Eye | Meibomian Gland Dysfunction

Canada, Australia, New Zealand
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects

H7N9 Influenza Vaccine

Taiwan
Allarity Therapeutics
Medical Prognosis Institute A/S; Smerud Medical Research International AS

Terminated

Safety and Pharmacokinetics of Rising Doses of APO010 in Relapsed/Refractory Multiple Myeloma Patients Selected by DRP (SMR-3184)

Relapsed/Refractory Multiple Myeloma

Denmark
Onxeo

Completed

A Phase I Dose Finding Study of APO010 in Patients With Solid Tumors (AP1001)

Cancer

Switzerland
Saad Jamshed MD
Sanofi

Completed

Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy (IMMUNE)

Cancer | Influenza Viral Infections

United States
USDA Grand Forks Human Nutrition Research Center

Completed

The Juice Study: Sensitivity of Skin Carotenoid Status to Detect Change in Intake

Overweight

United States
Boehringer Ingelheim

Completed

BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis

Psoriasis
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma

Pancreatic Cancer

United States
University of Wisconsin, Madison
National Center for Complementary and Integrative Health (NCCIH)

Completed

Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy

Asthma

United States
Shanghai Zhongshan Hospital
Shanghai Changzheng Hospital

Recruiting

Selenious Yeast in CLL Patients w/o Indication of Chemotherapy

Chronic Lymphocytic Leukemia Stage A(0) | Chronic Lymphocytic Leukemia Stage A(I) | Chronic Lymphocytic Leukemia Stage A(II) | Chronic Lymphocytic Leukaemia Stage B(I)

China
Universitätsklinikum Hamburg-Eppendorf
Erasmus Medical Center; German Center for Infection Research; Coalition for Epidemic... and other collaborators

Active, not recruiting

Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS (MVA-MERS-S)

MERS (Middle East Respiratory Syndrome)

Germany, Netherlands
Microphyt
Texas A&M University

Completed

Efficacy of a Microalgae Extract PhaeoSOL Combined With Natural Stimulant on Cognitive Function and Gaming Performance of Video Gamers (PHAEOSOL-TWO)

Cognitive Function | Video Gamers

United States
Aclaris Therapeutics, Inc.

Terminated

A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

Alopecia Areata

United States
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection

Acute Upper Respiratory Infection

China
Boehringer Ingelheim

Completed

Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX Administered as Multiple Doses and Safety and Pharmacokinetics of BIRT 2584 XX Administered With and Without Food as Single Dose to Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)

Arthritis, Rheumatoid
Yale University

Completed

Neuroimmune Effects of Opioid Administration (NOA)

Drug Effect

United States
GEN İlaç ve Sağlık Ürünleri A.Ş.
Sulfateq B.V.

Recruiting

A First-In-Human Study of Single and Multiple Ascending Doses of Oral SUL-238 in Healthy Subjects

Healthy Subjects

Turkey
Sanofi Pasteur, a Sanofi Company

Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and Older

Influenza (Healthy Volunteers)

Taiwan

Search clinical trials for: MAP0010 high dose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations